+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Octapharma AG - logo

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. It develops human proteins that are derived from human plasma and human cell-lines. The company provides biopharmaceutical products and therapies for haematology, intensive care & emergency medicine, and immunotherapy. Octapharma owns and operates six state of the art plants, employing over 6,000 workers globally. It was founded in 1983 by Wolfgang Marguerre.

From
From
From
From
From
From
Plasma Fractionation Market 2024-2028 - Product Thumbnail Image

Plasma Fractionation Market 2024-2028

  • Report
  • December 2023
  • 163 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1000 Pages
  • Global
From
Primary Immunodeficiency Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Immunodeficiency Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 136 Pages
  • Global
From
Immunoglobulins: Global Market Outlook - Product Thumbnail Image

Immunoglobulins: Global Market Outlook

  • Report
  • March 2023
  • 64 Pages
  • Global
From
Immunoglobulins Market - Global Outlook & Forecast 2021-2026 - Product Thumbnail Image

Immunoglobulins Market - Global Outlook & Forecast 2021-2026

  • Report
  • September 2021
  • 262 Pages
  • Global
From
From
Blood and Blood Components Market Report 2025 - Product Thumbnail Image

Blood and Blood Components Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Plasma Protein Therapeutics Market Report 2025 - Product Thumbnail Image

Plasma Protein Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator